Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review

Author(s): 
Zare-Shahabadi A1
Rashidian A4
Sahraian MA2
Rezaei N1
Abstract: 

Multiple sclerosis is a chronic immune-mediated disease of the nervous system. In the early disease course, axonal loss and neurodegeneration occurs that could possibly lead to irreversible neurological impairments. Preventing brain atrophy may have important clinical implications affecting treatment decisions in the future. In recent years, research efforts have directed towards finding agents to modify the disease and reduce brain volume loss. Intravenous immunoglobulin (IVIg) may have some potential roles in this regard.

URL: 
https://www.ncbi.nlm.nih.gov/pubmed/?term=Potential+role+of+immunoglobulin+replacement+therapy+on+MRI+measures+in+multiple+sclerosis%3A+a+systematic+review

Contact Us

Research Center for Immunodeficiencies

Address: Pediatrics Center of Excellence, Children’s Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran

Research Center For immunodeficiency

Research Center For immunodeficiency